[Report and Summary of Expert Meeting] The 3rd AMR Global Expert Meeting: Tokyo AMR One-Health Conference Side Event ~ Measures Necessary at Home and Abroad for Promotion of the Action Plan (November 14, 2017)
date : 4/12/2018
Tags: AMR
![[Report and Summary of Expert Meeting] The 3rd AMR Global Expert Meeting: Tokyo AMR One-Health Conference Side Event ~ Measures Necessary at Home and Abroad for Promotion of the Action Plan (November 14, 2017)](https://hgpi.org/en/wp-content/uploads/sites/2/3rd-AMR_JPNENG.png)
![](http://www.hgpi.org/photo/3rd AMR_TOP.jpg)
- Based on scientific evidence, Japan should consider the introduction of equipment for genetic diagnostic testing at an early date, as well as ways of promoting the utilization of genetic testing in clinical settings while also keeping in mind the limitations of insurance coverage.
- To prevent outbreaks at medical facilities, Japan should work to create an environment that makes early containment possible, including by offering public support for the storage of surveillance cultures, and by promoting diagnostic thoroughness in order to prevent mass outbreaks, and an environment that encourages early containment.
- To counteract infectious diseases at elderly care facilities or facilities where genetic diagnoses aren’t available, Japan should promote educational environments that can foster professionals such as microbiologists, or others with knowledge about public health.
- -Alongside push incentives (subsidies for drug development) for R&D at universities and pharmaceutical companies, it is important to implement pull incentives (incentives designed to reward drug development or provide returns on investment) that could help to increase the profit predictability for antibiotics for which low returns are expected and reflect the value of the drugs in their prices by considering how the drugs would be used under ideal situations where drugs are used appropriately.
- To enable the permanent monitoring of AMR, Japan must consider methods for highly reliable, cross-specialty data collection and utilization, as well as data analysis methods in the short-term.
- In order to comprehensively collect and utilize information about the kinds of resistant bacteria that commonly develop at elderly care facilities, Japan should consider working to promote the collection and utilization of data via regional networks.
- In order to facilitate correct understanding about infectious diseases among governments, medical facilities, and citizens, and in order to make it possible for Japan to consider, as a country, what safety measures should be implemented, Japan should create a culture of broadly sharing data on the usage of antibacterial drugs and other relevant issues.
- Japan should support the creation of scientific evidence that meets global standards for quality and reliability that has high, world-wide reliability and consider mechanisms for returning this evidence to clinical settings and to the public.
- Japan should promote cooperation between the technology sector and pharmaceutical companies. We should also support the sharing of data among governments, industry, and academia.
- Japan should display international leadership in combating AMR by investing funds in the promotion of basic research, both domestic and foreign, and in the maintenance and promotion of medical systems.
- In order to bolster the efforts of the One Health Approach, Japan should consider how to establish innovative mechanisms that would promote cooperation among industry, government, and academia, including in the agricultural and environmental fields.
- Along with ensuring access to antibacterial drugs in such a way that takes into account the actual circumstances of regional medical systems, Japan should go even further to exhaustively promote the proper use of antibacterial drugs in order to prevent the proliferation of resistant bacteria.
- Japan should recognize that AMR is a global concern and promote the further implementation of its National Action Plan, including from the perspective of the One Health Approach.
- Japan should work to communicate information about AMR around the world in the form of an action package that includes specific measures for achieving the goals specified in the action plan.
- While promoting the international development of advanced technologies to counteract infectious diseases, Japan should consider bilateral cooperation aimed at achieving universal health coverage (UHC) globally, as well as technological collaboration among specialists working in collaboration with the UN and other international agencies, and mechanisms that promote R&D.
- Japan should work independently as well to foster the international cooperation for the initiatives of the action plan.
- From the perspective of the One Health Approach, Japan should maintain an environment conducive to the sharing of initiatives across government organizations, academic research institutes, and industry related to AMR countermeasures, which are linked to a wide variety of issues such as the environment and food supplies.
- Not only governments, industry, and academia, but also the media and other stakeholders should take an active role in conveying correct information to the public.
- Kiyoshi Kurokawa (Chairman, Health and Global Policy Institute)
![](http://www.hgpi.org/photo/3rd AMR Kiyoshi Kurokawa.jpg)
- Chieko Ikeda (Senior Assistant Minister for Global Health, Ministry of Health, Labour and Welfare)
![](http://www.hgpi.org/photo/3rd AMR Chieko Ikeda.jpg)
- Chifumi Umeda (Executive Officer in charge of the Vaccine Business Unit and the Acute Diseases & Hospital Products Business Unit, MSD K.K.)
- Mitsuo Kaku (Professor, Infection Control and Laboratory Diagnostics, Internal Medicine, Department of Medical Sciences, Graduate School of Medicine, Tohoku University)
- Tomohiko Makino (Medical Officer, WHO West Pacific Regional Office)
- Michael Bell (Deputy Director, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention)
- Manami Takamatsu (Manager, Health and Global Policy Institute)
![](http://www.hgpi.org/photo/3rd AMR_Panel.jpg)
- Dame Sally Davies (Chief Medical Adviser to the UK Government/ Co-convener of the UN Inter-Agency Co-ordination Group on AMR.)
![](http://www.hgpi.org/photo/3rd AMR_Sally Davies.jpg)
- Yasuhisa Shiozaki (Member of the House of Representatives/ Former Minister of Health, Labour and Welfare)
![](http://www.hgpi.org/photo/3rd AMR Yasuhisa Shiozaki.jpg)
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Patient and Public Involvement (PPI) Support Project “Promoting PPI in the Policymaking Process” (May 14, 2024)
- [Public Comment Submission] “The Fifth Fundamental Plan for Establishing a Sound Material-Cycle Society (Draft)” (May 22, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)